[HTML] sciencedirect.com

[HTML][HTML] Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate …

S Bianchi, A Mosca, A Dalla Volta, V Prati… - European Journal of …, 2021 - Elsevier
Background This study was designed to demonstrate the non-inferiority (NI) in overall
survival (OS) of suspension of androgen deprivation therapy (ADT) versus maintenance and …
被引用次数：5 相关文章
[PDF] uniupo.it

[PDF][PDF] Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate …

S Bianchi, A Mosca, A Dalla Volta, V Prati… - EUROPEAN …, 2021 - iris.uniupo.it
Background: This study was designed to demonstrate the non-inferiority (NI) in overall
survival (OS) of suspension of androgen deprivation therapy (ADT) versus maintenance and …

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer …

S Bianchi, A Mosca, A Dalla Volta, V Prati… - EUROPEAN JOURNAL …, 2021 - iris.unibs.it
Background: This study was designed to demonstrate the non-inferiority (NI) in overall
survival (OS) of suspension of androgen deprivation therapy (ADT) versus maintenance and …

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer …

S Bianchi, A Mosca, A Dalla Volta, V Prati… - European Journal of …, 2021 - ejcancer.com
Background This study was designed to demonstrate the non-inferiority (NI) in overall
survival (OS) of suspension of androgen deprivation therapy (ADT) versus maintenance and …

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer …

S Bianchi, A Mosca, A Dalla Volta, V Prati… - European Journal of …, 2021 - research.uniupo.it
Background: This study was designed to demonstrate the non-inferiority (NI) in overall
survival (OS) of suspension of androgen deprivation therapy (ADT) versus maintenance and …

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer …

S Bianchi, A Mosca, A Dalla Volta, V Prati… - European Journal of …, 2021 - europepmc.org
Background This study was designed to demonstrate the non-inferiority (NI) in overall
survival (OS) of suspension of androgen deprivation therapy (ADT) versus maintenance and …
[PDF] academia.edu

[PDF][PDF] Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate …

S Bianchi, A Mosca, A Dalla Volta, V Prati… - European Journal of …, 2021 - academia.edu
Background: This study was designed to demonstrate the non-inferiority (NI) in overall
survival (OS) of suspension of androgen deprivation therapy (ADT) versus maintenance and …

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer …

S Bianchi, A Mosca, A Dalla Volta, V Prati… - EUROPEAN JOURNAL …, 2021 - iris.unito.it
This study was designed to demonstrate the non-inferiority (NI) in overall survival (OS) of
suspension of androgen deprivation therapy (ADT) versus maintenance and intermittent …

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer …

S Bianchi, A Mosca, A Dalla Volta… - … journal of cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Background This study was designed to demonstrate the non-inferiority (NI) in overall
survival (OS) of suspension of androgen deprivation therapy (ADT) versus maintenance and …
[PDF] uniupo.it

[PDF][PDF] Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate …

S Bianchi, A Mosca, A Dalla Volta, V Prati… - European Journal of …, 2021 - iris.uniupo.it
Background: This study was designed to demonstrate the non-inferiority (NI) in overall
survival (OS) of suspension of androgen deprivation therapy (ADT) versus maintenance and …